LOGOLOGOLOGOLOGO
    • About us
      • What we do
      • Who we are
        • Governance
        • Staff
        • Vacancies
    • Members
      • EuropaBio Members
      • About Membership
    • How we work
      • Healthcare Biotechnology Council
        • Patient BioForum
        • Study – Impact of the EU’s General Pharmaceutical Legislation
      • Industrial Biotechnology Council
        • EFIB
        • Microorganisms
      • National Associations Council
      • SME Platform
      • Biomanufacturing Platform
        • Biotechnology in our Lives
    • Activities
      • 25 Years of Innovation
      • The EU Biotech Act
      • European Biotech Week
      • EU Projects
        • PRIMED Project
        • APROVALS Project
    • News & Events
      • News
      • Events
    • Library
    Become a member
    ✕

    Ecolab Life Sciences joins EuropaBio: Helping Shape the Future of Life Sciences Manufacturing in Europe

    03/02/2026

    PRESS RELEASE

    Brussels, 3 February 2026 - EuropaBio today announced that Ecolab Life Sciences has joined as a new member, bringing decades of experience supporting biopharmaceutical manufacturers in maintaining product integrity, ensuring patient safety, and navigating complex regulatory environments.

    As part of Ecolab Inc., a Fortune 500 company founded in 1923, Ecolab Life Sciences leverages over a century of innovation and manufacturing to support biopharmaceutical manufacturers globally. With operations spanning critical stages of drug development and production, the company helps ensure product quality, patient safety, and regulatory compliance across the life sciences value chain.

    The company's portfolio includes contamination control solutions, technologies for automated bio decontamination, drug purification resins, active pharmaceutical ingredients (APIs), water circularity solutions and expert technical support services. These integrated solutions help manufacturers achieve contamination control excellence while enhancing operational efficiency and supporting optimised manufacturing practices.

    "We are committed to advancing the biopharmaceutical industry through science-based innovation and regulatory excellence," said Andrea Wegner, Head of Global Regulatory Affairs at Ecolab Life Sciences. "Joining EuropaBio represents a natural extension of our long-term commitment to the life sciences industry and our mission to help accelerate patient access to life-saving therapies through robust regulatory frameworks. We look forward to contributing our deep regulatory expertise, global manufacturing insights, and innovation-driven perspective to help foster a supportive environment for biotechnology advancement across Europe."

    Dr. Claire Skentelbery, Director General of EuropaBio, commented: "Ecolab is the perfect example of the diversity of expertise and capacity that is needed to deliver a strong biotechnology ecosystem and industry. We are delighted that the Ecolab team brings its voice to EuropaBio's work in building a robust European biotech landscape."

    Through its membership in EuropaBio, Ecolab Life Sciences aims to contribute to the development of robust, regulatory frameworks that support innovation while ensuring patient safety and product quality. The company brings valuable experience in navigating complex regulatory environments and a proven track record of helping life science manufacturers achieve and maintain compliance with evolving global standards.

    Ecolab Life Sciences' membership reinforces EuropaBio's commitment to bringing together diverse industry stakeholders to drive innovation, promote regulatory excellence, and support the continued growth of Europe's biotechnology sector.

    For more information, please visit ecolab.com

    Ecolab Life Sciences joins EuropaBio: Helping Shape the Future of Life Sciences Manufacturing in Europe


    Download
    Share
    Adrian Lincoln
    Adrian Lincoln

    Related posts

    18/05/2026

    Biodefence & Biosecurity in focus for EuropaBio with dedicated Task Force


    Read more
    12/05/2026

    ‘Consistency, cooperation and practicality are the watch words’. EuropaBio reacts to provisional agreement on the Critical Medicines Act


    Read more
    08/05/2026

    Technovative Solutions Ltd. joins EuropaBio: Advancing AI‑Driven and Sustainable Innovation in Biotechnology


    Read more

    Important links

    • Biodefence & Biosecurity in focus for EuropaBio with dedicated Task Force
    • ‘Consistency, cooperation and practicality are the watch words’. EuropaBio reacts to provisional agreement on the Critical Medicines Act

    Categories in our Newsroom

    EBIO-white

    EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

    Contact us

    Extra links

    Members
    Staff
    Privacy policy
    Legal & cookies
    Events
    Newsroom

    Become a member

    Media pack

    © 2026 Europabio. All Rights Reserved. Designed by EYAS
    Become a member

    Vitamin B2

    The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

    Insulin

    Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.

    Detergents

    Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

    Clothes

    Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

    Algal Omega 3

    Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

    Cheese

    Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.